312 related articles for article (PubMed ID: 33343800)
1. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
[TBL] [Abstract][Full Text] [Related]
3. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
Maurer M; Giménez-Arnau A; Ensina LF; Chu CY; Jaumont X; Tassinari P
World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
[TBL] [Abstract][Full Text] [Related]
4. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
[TBL] [Abstract][Full Text] [Related]
5. Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study.
Thomsen SF; Pritzier EC; Anderson CD; Vaugelade-Baust N; Dodge R; Dahlborn AK; Vestergaard C
J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):1048-1055. PubMed ID: 28294420
[TBL] [Abstract][Full Text] [Related]
6. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
[TBL] [Abstract][Full Text] [Related]
7. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
[TBL] [Abstract][Full Text] [Related]
8. The socio-economic burden of H1-antihistamine-refractory chronic spontaneous urticaria in Germany.
Augustin M; Beier D; Branner J; Häckl D; Hampel R; Kramps T; Kurzen H; Lintener H; Melzer N; Müller M; Staubach P; Schwichtenberg U; Termeer C; Zink A; Nathan P; Maurer M
J Eur Acad Dermatol Venereol; 2024 May; ():. PubMed ID: 38733261
[TBL] [Abstract][Full Text] [Related]
9. A Specialized Therapeutic Approach to Chronic Urticaria Refractory to H1-Antihistamines Improves Disease Burden: The Spanish AWARE Experience.
Gimenez-Arnau A; Bartra J; Ferrer M; Jauregui I; Borbujo J; Figueras I; Muñoz-Bellido FJ; Pedraz J; Serra-Baldrich E; Tejedor-Alonso MA; Velasco M; Terradas P; Labrador M
J Investig Allergol Clin Immunol; 2022 Jun; 32(3):191-199. PubMed ID: 33349612
[TBL] [Abstract][Full Text] [Related]
10. Treating chronic urticaria refractory to H1-antihistamines in Russia: data from the AWARE study.
Danilycheva I; Emelyanov A; Meshkova R; Ukhanova O; Abdrakhmanov A; Litvin L
Postepy Dermatol Alergol; 2022 Jun; 39(3):509-516. PubMed ID: 35950113
[TBL] [Abstract][Full Text] [Related]
11. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study.
Kocatürk E; Can PK; Akbas PE; Copur M; Degirmentepe EN; Kızıltac K; Singer R
J Dermatol Sci; 2017 Jul; 87(1):60-69. PubMed ID: 28314658
[TBL] [Abstract][Full Text] [Related]
12. The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea.
Ye YM; Koh YI; Choi JH; Kim MA; Park JW; Kim TB; Nam YH; Chang YS; Park HS
Korean J Intern Med; 2022 Sep; 37(5):1050-1060. PubMed ID: 36068718
[TBL] [Abstract][Full Text] [Related]
13. Chronic urticaria in the real-life clinical practice setting in the UK: results from the noninterventional multicentre AWARE study.
Savic S; Leeman L; El-Shanawany T; Ellis R; Gach JE; Marinho S; Wahie S; Sargur R; Bewley AP; Nakonechna A; Randall R; Fragkas N; Somenzi O; Marsland A
Clin Exp Dermatol; 2020 Dec; 45(8):1003-1010. PubMed ID: 32246853
[TBL] [Abstract][Full Text] [Related]
14. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
[TBL] [Abstract][Full Text] [Related]
15. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Autologous Whole-Blood Injections in Patients with Refractory Chronic Spontaneous Urticaria.
Kitsioulis NA; Xepapadaki P; Roussaki-Schulze AV; Papadopoulos N; Zafiriou E
Int Arch Allergy Immunol; 2017; 172(3):161-166. PubMed ID: 28380487
[TBL] [Abstract][Full Text] [Related]
17. The Efficacy and Safety of High Dose (10 mg) of Desloratadine (Dazit® 10) in the Treatment of Chronic Spontaneous Urticaria in India: A Phase III, Multicentric, Open-Label, Single-Arm Study.
Kapadia S; Nageswaramma S; Shah K; Singh A; Mahajan SC; Deshpande A; Chakraborty S; Kar BR; Padmaja P; Bharija SC; Doshi M; Ghadge P; Gabhane M; Dharmadhikari S; Mane A; Mehta S
Cureus; 2024 Jan; 16(1):e53125. PubMed ID: 38420062
[TBL] [Abstract][Full Text] [Related]
18. Clinical experience of a chronic urticaria referral university center.
Andrade Coelho Dias G; Cunha Coelho F; Filippo P; Lacerda Pedrazzi D; Nogueira Arraes AC; Perelló MI; Chigres Kuschnir F; Costa E
Eur Ann Allergy Clin Immunol; 2020 May; 52(3):112-120. PubMed ID: 31287262
[No Abstract] [Full Text] [Related]
19. Unveiling Treatment Response Predictors in Predominant Subtypes of Chronic Inducible Urticaria.
Ornek Ozdemir S; Can PK; Degirmentepe EN; Kızıltaç K; Singer R; Kocatürk E
Int Arch Allergy Immunol; 2024 Jun; ():1-11. PubMed ID: 38889696
[TBL] [Abstract][Full Text] [Related]
20. Improvement of patient outcomes following therapeutic optimization of chronic urticaria: two-year data from France as part of the international real-life AWARE study.
Giordano-Labadie F; Becherel PA; Pralong P; Outtas O; Ruer-Mulard M; Berard F; Greco M; Lacour JP; Debons-Peyroutet M; Pelvet B; Lamirand A; Guillet G
Eur J Dermatol; 2021 Apr; 31(2):217-224. PubMed ID: 34001470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]